The ILCA25 program will include the most relevant topics in the field of liver cancer from basic and translational research to clinical management for patients with primary liver cancer, including hepatocellular carcinoma (HCC) or cholangiocarcinoma (CCA). The Conference will cover the most recent advances in screening/surveillance, diagnosis, treatment, and survivorship for patients with liver cancer.

International multidisciplinary experts will provide in-depth presentations and thought-provoking discussions to enhance knowledge and perspective on these current and very important topics in the field. Sessions will be highly interactive with plenty of room for discussion about open issues and future perspectives for patients with liver cancer. It will be an event-provoking paradigm shift in your clinical practice or research that is not to be missed.